MSI status plus immunoscore to select metastatic colorectal cancer patients for immunotherapies

Conference contribution


Publication Details

Author(s): Galon J, Mlecnik B, Hermitte F, Marliot F, Bifulco C, Lugli A, Nagtegaal ID, Hartmann A, Van Den Eynde M, Roehrl M, Ohashi P, Zavadova E, Torigoe T, Patel P, Wang Y, Kawakami Y, Marincola FM, Ascierto PA, Fox B, Pages F
Publisher: OXFORD UNIV PRESS
Publishing place: OXFORD
Publication year: 2018
Conference Proceedings Title: ANNALS OF ONCOLOGY
ISSN: 0923-7534


FAU Authors / FAU Editors

Hartmann, Arndt Prof. Dr. med.
Lehrstuhl für Allgemeine Pathologie und Pathologische Anatomie


External institutions
AbbVie Deutschland GmbH & Co. KG
Cliniques universitaires Saint-Luc (CHU St-Luc)
Earle A. Chiles Research Institute at the Robert W. Franz Cancer Center
Georges Pompidou European Hospital / Hôpital Européen Georges-Pompidou (HEGP)
Gujarat Cancer & Research Institute
HalioDx - Luminy Biotech Entreprises
Inselspital, Universitätsspital Bern
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"
Keio University / 慶應義塾大学
Memorial Sloan Kettering Cancer Center
National Institute for Health and Medical Research / Institut national de la santé et de la recherche médicale (INSERM)
Providence Portland Medical Center
Radboud University Nijmegen
Sapporo Medical University / 札幌医科大学
University Health Network (UHN)
Univerzita Karlova v Praze / Charles University in Prague
Xi'an Jiaotong University (XJTU) / 西安交通大学


How to cite

APA:
Galon, J., Mlecnik, B., Hermitte, F., Marliot, F., Bifulco, C., Lugli, A.,... Pages, F. (2018). MSI status plus immunoscore to select metastatic colorectal cancer patients for immunotherapies. In ANNALS OF ONCOLOGY. Geneva, CH: OXFORD: OXFORD UNIV PRESS.

MLA:
Galon, J., et al. "MSI status plus immunoscore to select metastatic colorectal cancer patients for immunotherapies." Proceedings of the ESMO Immuno-Oncology Congress, Geneva OXFORD: OXFORD UNIV PRESS, 2018.

BibTeX: 

Last updated on 2019-20-03 at 12:23